Lucira Health, Inc. (LHDX): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
LHDX Stock Price Chart Interactive Chart >
LHDX Price/Volume Stats
| Current price | $4.85 | 52-week high | $37.99 |
| Prev. close | $4.81 | 52-week low | $4.23 |
| Day low | $4.75 | Volume | 381,700 |
| Day high | $4.91 | Avg. volume | 1,688,560 |
| 50-day MA | $6.08 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 187.08M |
Lucira Health, Inc. (LHDX) Company Bio
Lucira Health, Inc. produces and distributes medical equipment. The Company offers disposable test kits to detect DNA and RNA of infectious diseases. Lucira Health markets its products in the United States.
Latest LHDX News From Around the Web
Below are the latest news stories about Lucira Health Inc that investors may wish to consider to help them evaluate LHDX as an investment opportunity.
Lucira Health appoints medtech veteran Kevin Collins as CROLucira Health (LHDX) announces Kevin Collins has joined the company as chief revenue officer with global revenue responsibility.Most recently, he was Vice President of International Commercial Operations at Outset Medical (OM).Shares are down 3.19% PM.... |
LUCIRA™ HEALTH Hires Chief Revenue Officer Kevin CollinsLucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced medtech veteran Kevin Collins has joined the company as Chief Revenue Officer with global revenue responsibility. |
Is Lucira Health a Good Stock to Buy Right Now?Shares of Lucira Health (NASDAQ: LHDX) exploded out of the gate when the company made its stock market debut in February. Lucira Health's over-the-counter COVID-19 tests racked up millions of dollars in sales during the first three months of 2021, leading some investors to wonder if this beaten-down stock can bounce back. |
Lucira Health to Participate in William Blair 41st Annual Growth Stock ConferenceEMERYVILLE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will be participating in the William Blair 41st Annual Growth Stock Conference. Lucira Health’s management is scheduled to participate in the conference on Wednesday, June 2, 2021, at 10:40 a.m. PT / 1:40 p.m. ET. Interested parties can access the live and archived webcast at ir.lucirahealth.com. About Lucira HealthLucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform pro... |
Lucira Health, Inc. (LHDX) Q1 2021 Earnings Call TranscriptEarlier today, Lucira Health received -- released financial results for the first quarter ended March 31, 2021. Joining me today on today's call are Erik Engelson, president and chief executive officer; and Dan George, chief financial officer. |
LHDX Price Returns
| 1-mo | 3.19% |
| 3-mo | -67.77% |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...